Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented plans for a registrational program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback